Passage BIO, Inc.·4

Jun 15, 5:24 PM ET

Forman Mark S 4

4 · Passage BIO, Inc. · Filed Jun 15, 2022

Insider Transaction Report

Form 4
Period: 2022-06-13
Forman Mark S
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-06-13+136,000136,000 total
    Exercise: $2.29Exp: 2032-06-12Common Stock (136,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION